Interestingly, both CNE2/LMP1 and CNE2/Vector cells had an increased expression of PDCD4 and Fas-L in response to cisplatin treatment, suggesting PDCD4 and Fas-L are the effectors for cisplatin [45,46] in NPC cells. This evidence concerns the gene FASLG and nasopharyngeal carcinoma.